Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Effect of in utero growth retardation on lung function at follow-up of prematurely born infants

A. Greenough, B. Yuksel, P. Cheeseman
European Respiratory Journal 2004 24: 731-733; DOI: 10.1183/09031936.04.00060304
A. Greenough
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B. Yuksel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. Cheeseman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

The aim of the study was to determine if prematurely born children who had suffered intra-uterine growth retardation (IUGR) had more severe lung function abnormalities than those born an appropriate weight for gestational age (AGA).

Analysis of the lung function results of 119 infants (median (range) gestational age of 30 (23–35) weeks) was undertaken. In total, 31 of the infants had suffered IUGR and were born small for gestational age (SGA). Functional residual capacity and airways resistance (Raw) were measured at a median post-natal age of 10 (6–24) months. Specific airway conductance (sGaw) was calculated from thoracic gas volume and Raw.

The SGA children were born at a greater gestational age and had a lower body weight at testing than the AGA children. Raw and sGaw differed between the SGA and AGA children. Regression analysis demonstrated that lung volumes were significantly related to body weight at testing, Raw was related to IUGR, maternal smoking and bronchopulmonary dysplasia, and sGaw to maternal smoking.

In conclusion, these results suggest that prematurely born infants who have suffered intra-uterine growth retardation may be at increased risk of impaired lung function at follow-up.

  • Lung volume measurements
  • prematurity

B. Yuksel was supported by the Joint Research Committee of King's College Hospital.

Children born prematurely may suffer respiratory morbidity at follow-up 1 and, as a consequence, have a high healthcare utilisation 2. In utero growth retardation (IUGR) may also be a risk factor for respiratory morbidity in childhood. Both wheezing and respiratory infections 3 appear more common in children who suffered IUGR and, as a consequence, were small for gestational age (SGA) at birth. In addition, a significant association between birth weight (adjusted for gestational age) and lung function (forced vital capacity and forced expiratory volume in one second (FEV1)) has been reported in children aged 5–11 5 and 7–15 yrs who were born SGA, and had lower maximum mid-expiratory flows, but not lung volumes 6. Diminished airway function has even been reported in adults who were born of low birth weight 7, leading to the speculation that the association is mediated by foetal programming. Therefore, it seems likely that, amongst children born prematurely, those who were SGA, compared with those who were born at an appropriate weight for gestation (AGA), would have worse lung function abnormalities. The aim of this study was to test that hypothesis by comparing the lung function test results of SGA with AGA children born prematurely and examined during prospective follow-up.

Materials and methods

Study subjects

A total of 119 children with a median (range) gestational age of 30 (23–35) weeks were studied. Thirty-one of the children had suffered IUGR and been born SGA, with a birth weight of <10th percentile for gestational age. Parents gave informed consent for their child to take part and the study was approved by the King's College Hospital Ethics Committee.

Study design

Infants were eligible for entry into the cohort if they had a birth weight of <1,500 g, or their birth weight was 1,500–2,000 g and they had required mechanical ventilation in the neonatal period. Infants with chromosomal or congenital anomalies were excluded. Lung function had been measured during the first 2 yrs in a cohort of prematurely born children, who were prospectively followed. Lung function results from the cohort have been previously reported 8. Lung function measurements were performed in the Paediatric Respiratory Laboratory, King's College Hospital. Children were not tested for ≥48 h after having respiratory symptoms (wheeze and/or cough) or an upper respiratory tract infection. Measurements were made while the child was in quiet sleep following administration of 80–100 mg·kg−1 of chloral hydrate.

Methods

Functional residual capacity (FRCpleth) and airway resistance (Raw) were measured using a whole body plethysmograph (Hammersmith Hospital, London, UK). From FRCpleth and Raw, specific airway conductance (sGaw) was calculated. The techniques used to measure lung function have been described in detail previously 8. The child breathed through a face mask, which was connected to a rebreathing bag via a heated pneumotachograph and was sealed around the child's nose and mouth using silicone putty to ensure an airtight seal. The child breathed through a heated, humidified rebreathing system to avoid box pressure changes due to heating and cooling of respired gas. FRCpleth was measured at the end of a normal inspiration, and Raw was measured at two-thirds of maximum respiratory flow using the techniques of Dubois and colleagues 9, suitably modified for use in young children. FRCpleth was calculated from five breaths during an occlusion, and the reported value was adjusted to end-expiratory lung volume. At least five separate occlusions were made. Raw was calculated from ≥10 breaths. All measurements were corrected for the apparatus dead space, including the face mask (15 mL) and resistance (8 cm H2O·L−1·s−1). The coefficients of variation of FRCpleth and Raw were 6% and 9%, respectively. The plethysmograph was calibrated before and after each measurement. In vitro calibration of the plethysmograph demonstrated a 3% difference in the volume measurement.

After completion of the measurements of FRCpleth and Raw, FRC was measured using a helium gas dilution technique (FRCHe). The child's face mask was connected to a water-sealed spirometer (Gould pulmonet III; Gould, Cleveland, OH, USA). The spirometer had an internal carbon dioxide absorber, an adjustable oxygen supply and a total volume of 6 L. It incorporated a digital display of FRC that was recorded at 15-s intervals. Equilibration was assumed to have occurred when there had been no change in the FRC readout over 30 s. All the FRC traces were coded and analysed without knowledge of the clinical details. From the trace, the equilibration point and end-expiratory level were determined, and FRC was calculated. The results were then converted to body temperature, pressure and saturation conditions. The accuracy of the spirometer was checked daily using a calibrated syringe (Vitalograph, Buckingham, UK).

Analysis

Differences between the groups were assessed for statistical significance using ANOVA Kruskal-Wallis, Fisher's exact test or Chi-squared test, as appropriate. AGA children had a birth weight 10–90th percentile for gestational age. Mothers were described as smoking if they smoked during pregnancy, and bronchopulmonary dysplasia (BPD) was diagnosed if the children had been oxygen dependent beyond 36 weeks post-menstrual age. Any multivariate association with lung function results were obtained by using multiple linear regression analysis; dependent variables were FRCpleth, FRCHe, Raw and sGaw. Numeric independent variables tested were IUGR, maternal smoking and BPD. In the multivariate analysis of Raw and sGaw, weight at follow-up was excluded as there is not a direct relationship between Raw and weight.

Results

The SGA children were born at a greater gestational age (p<0.0001), but were of similar birth weight to the AGA children. The SGA children were lighter at the time of measurement (p=0.0036; table 1⇓). The median FRCpleth and FRCHe did not differ significantly between the SGA and AGA children, but the SGA compared with the AGA children had a higher median Raw (p=0.004) and a lower median sGaw (p=0.036; table 1⇓).

Multiple regression analysis demonstrated that FRCpleth and FRCHe at the time of measurement were significantly related to weight at testing (both p<0.0001), independently of all other factors (see Analysis). Raw was significantly related to IUGR (p=0.0227), maternal smoking (p=0.0008) and BPD (p=0.0308), independently of other factors, and sGaw was significantly related to maternal smoking (p=0.0194) independently of other factors (see Analysis).

Discussion

The current study has demonstrated that amongst prematurely born children, those born SGA had significantly different lung function at follow-up compared with those born AGA. The same techniques of measurement were used in both groups, thus the comparison between them is robust. A birth weight of <10th percentile for gestational age was used to diagnose SGA. It is possible that, if a birth weight of <3rd percentile for gestational age was used, differences between the two groups might have been more marked. The children born SGA had significantly higher Raw and lower sGaw than those born AGA (table 1⇓). Regression analysis demonstrated that, when other factors were taken into account, a raised Raw was significantly associated with IUGR. Diminished airway function has been demonstrated in SGA infants aged 6 weeks when examined using partial and raised volume expiratory manoeuvres 11. However, the differences between AGA and SGA infants disappeared when body size and sex were taken into account, causing the authors to suggest that diminished airway function in SGA infants was primarily due to impaired somatic growth 11. More recent analysis of the whole cohort, including infants born to smoking mothers, as well as those born to nonsmoking mothers previously reported 11, demonstrated that low birth weight for gestation did account for a proportion of the reduction in airway function in infants born after 35 weeks of gestation 12. The findings of the current study are in keeping with those results 13, as the regression analysis demonstrated Raw to be significantly related to IUGR, as well as smoking. However, sGaw, which takes into account lung volume and is primarily influenced by bodyweight as demonstrated by the regression analysis, was only significantly related to maternal smoking.

Examination at 15 yrs of age demonstrated children born with a very low birth weight to have medium and small airway obstruction when compared with controls matched for age, sex and school 14. In contrast to the findings of the present study, the abnormalities were demonstrated to relate to prematurity, rather than IUGR or the receiving of respiratory support during the neonatal period. However, the cohort in Anand et al. 14 was born in 1980–1981 and, thus, before the routine use of antenatal steroids and post-natal surfactant. The results from the current study support earlier findings demonstrating a significant association between birth weight and FEV1 in children aged 5–11 yrs 5 and the diminished airway function noted in adults of low birth weight 7.

Lung function had originally been measured in this cohort to further understand the effect of premature birth on respiratory morbidity at follow-up and the current study has subsequently examined the influence of IUGR. Nevertheless, the results are comparable with findings reported from children born at or near term 5. In addition, regression analysis demonstrated significant associations of a raised Raw and lower sGaw at follow-up with maternal smoking, which is consistent with previous findings 15. Maternal smoking during pregnancy has been shown to be associated with a reduction in flow at FRC 15.

The SGA children were born at a significantly greater gestational age than the AGA children. Immaturity at birth is a major risk factor for the development of respiratory distress syndrome (RDS) and BPD. It had been assumed that growth-retarded infants, as a result of stress in utero, would have improved respiratory outcome. However, there are reports of SGA infants being more likely to develop RDS 16 and BPD 12 and require more ventilatory support 17. In this study, the SGA infants, compared with the rest of the cohort, tended to require a shorter duration of respiratory support (table 1⇓), and a smaller proportion developed BPD, although this did not reach statistical significance. The regression analysis demonstrated both IUGR and BPD influenced Raw at follow-up.

As has been noted before, the SGA compared with the AGA children had significantly lower body weights at follow-up 18. As a consequence, the influence of weight at follow-up on lung volumes was examined in the regression analysis. This highlighted that weight at testing was significantly related to lung volume independently of all other factors, emphasising the importance of taking body weight into account when analysing lung function at follow-up in similar populations in future studies. Length at follow-up was not measured, so the current authors cannot comment on whether lung volumes were similarly significantly related to length.

In conclusion, children born very prematurely who have suffered intra-uterine growth retardation had significantly different lung function at follow-up compared with appropriate weight for gestation children. The cause and prevention of this problem merits investigation.

View this table:
  • View inline
  • View popup
Table 1—

Comparison of the demographics and lung function test results of the small for gestational age (SGA) and appropriate weight for gestation (AGA) children

Footnotes

  • ↵ For editorial comments see page 722.

  • Received May 20, 2004.
  • Accepted July 12, 2004.
  • © ERS Journals Ltd

References

  1. ↵
    Giffin FJ, Greenough A, Yuksel B. Prediction of respiratory morbidity in the third year of life in children born prematurely. Acta Paediatr 1994;83:157–158.
    OpenUrlCrossRefPubMed
  2. ↵
    Greenough A, Cox S, Alexander J, et al. Health care utilisation of chronic lung disease infants related to hospitilisation for respiratory syncytial virus infection. Arch Dis Child 2001;85:463–468.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Vik T, Vatten L, Markestad T, Ahlsten G, Jacobsen G, Bakketeig LS. Morbidity during the first month of life in small for gestational age infants. Arch Dis Child 1996;75:F33–F37.
    OpenUrl
  4. Brooke AM, Lambert PC, Burton PR, Clarke C, Luyt DK, Simpson H. The natural history of respiratory symptoms in preschool children. Am J Respir Crit Care Med 1995;152:1872–1878.
    OpenUrlPubMedWeb of Science
  5. ↵
    Rona RJ, Guildford MC, Clunn S. Effects of prematurity and intrauterine growth on respiratory health and lung function in childhood. BMJ 1993;306:817–820.
  6. ↵
    Nikolayev K, Heinonen K, Hakulinen A, Lansimies E. Effects of intrauterine growth retardation and prematurity on spirometric flow values and lung volumes at school age in twin pairs. Pediatr Pulmonol 1998;25:367–370.
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    Barker DJ, Godfrey KM, Fall C, Osmond C, Winter PD, Shaheen SO. Relation of birthweight and childhood respiratoryinfection to adult lung function and death from chronic obstructive airway disease. BMJ 1991;303:671–675.
  8. ↵
    Giffin F, Greenough A, Yuksel B. Relationship between lung function results in the first year of life and respiratory morbidity in early childhood in patients born prematurely. Pediatr Pulmonol 1994;18:290–294.
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    Dubois AB, Botelho SY, Bednell GN. A rapid plethysmographic method for measuring thoracic gas volume: a comparison with a nitrogen washout method for measuring functional residual capacity in normal subjects. J Clin Invest 1956;35:322–326.
  10. Dubois AB, Botelho SY, Comree JM. A new method for measuring airway resistance in man using a body plethysmograph: values in normal subjects and in patients with respiratory disease. J Clin Invest 1956;35:327–332.
  11. ↵
    Lum S, Hoo AF, Dezateux C, et al. The association between birthweight, sex and airway function in infants of non-smoking mothers. Am J Respir Crit Care Med 2001;164:2078–2084.
    OpenUrlPubMedWeb of Science
  12. ↵
    Bardin C, Zelkrowitz P, Papgeorgiou A. Outcome of small for gestational age and appropriate for gestational age infants born before 27 weeks of gestation. Pediatrics 1997;100:E4.
    OpenUrl
  13. ↵
    Dezateux C, Lum S, Hoo A-F, Hawdon J, Costeloe K, Stocks J. Low birthweight for gestation and airway function in infancy: exploring the fetal origins hypothesis. Thorax 2004;59:60–66.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    Anand D, Stevenson CJ, West CR, Pharoah PO. Lung function and respiratory health in adolescents of very low birthweight. Arch Dis Child 2003;88:135–138.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    Tager IB, Ngo L, Hanrahan JP. Maternal smoking during pregnancy. Am J Respir Crit Care Med 1995;152:977–983.
    OpenUrlPubMedWeb of Science
  16. ↵
    Bernstein IM, Horbar JD, Badger GJ, Ohlsson A, Golan A. Morbidity and mortality among very low birthweight neonates with intrauterine growth restriction. The Vermont Oxford Network. Am J Obstet Gynecol 2000;182:198–206.
    OpenUrlCrossRefPubMedWeb of Science
  17. ↵
    Regev RH, Lusky A, Dolfin T, Litmanovitz I, Arnon S, Reichman B. Israel Neonatal Network. Excess mortality and morbidity among small for gestational age premature infants: a population based study. J Pediatrics 2003;143:186–191.
    OpenUrlCrossRefPubMedWeb of Science
  18. ↵
    Clarke RH, Thomas P, Peabody J. Extrauterine growth restriction remains a serious problem in prematurely born neonates. Pediatrics 2003;111:986–990.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
View this article with LENS
Vol 24 Issue 5 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Effect of in utero growth retardation on lung function at follow-up of prematurely born infants
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Effect of in utero growth retardation on lung function at follow-up of prematurely born infants
A. Greenough, B. Yuksel, P. Cheeseman
European Respiratory Journal Nov 2004, 24 (5) 731-733; DOI: 10.1183/09031936.04.00060304

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Effect of in utero growth retardation on lung function at follow-up of prematurely born infants
A. Greenough, B. Yuksel, P. Cheeseman
European Respiratory Journal Nov 2004, 24 (5) 731-733; DOI: 10.1183/09031936.04.00060304
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Materials and methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society